ArticleCancer biology & therapy2019

Slight advantages of nimotuzumab versus cetuximab plus concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

Wang Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.